After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation ...
Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
The Hunter Medical Research Institute (HMRI) has signed a memorandum of understanding (MoU) with Novartis Australia for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback